Kits Eyecare Ltd.
TSX:KITS.TOSpecialty Retail
-$0.18 today
- Market cap
- $650.54M
- Beta
- 0.20
- P/E (TTM)
- 126.0
- EPS (TTM)
- $0.10
Volume 0.08M
Average 0.14M
KITS.TO EBITDA
Earnings before interest, taxes, depreciation, and amortization; a proxy for operating profit before non-cash and financing charges.
Kits Eyecare Ltd.TSX: KITS.TO
EBITDA · Q1 FY2026 · quarter ended Mar 2026
EBITDA growth accelerates
Q1 FY2026 EBITDA of CA$3.68M rose 18.7% year over year, ahead of the -2.5% change in trailing-twelve-month EBITDA. Sequentially, it rose 33.0% from the prior quarter.
Context
- EBITDA amounted to 5.3% of revenue in FY2025, unchanged from a year earlier.
- EBITDA increased in 3 of the last 3 fiscal years.
- FY2025 was the highest annual figure in the 4 fiscal years shown.
What to watch
Whether EBITDA reaches the consensus estimate from 7 analysts of CA$10.94M (+2.8%) for the fiscal year ending Dec 2026, a slowdown from the +28.1% reported in FY2025.
Sources:Income Statement Analyst consensus estimates Text generated from reported figures; not investment advice.
- Latest quarterMar 2026
- CA$3.68M+33.0% QoQ
- Last fiscal yearDec 2025
- CA$10.65M+28.1% YoY
- LTMMar 2026
- CA$10M-2.5% YoY
| Horizon | Past | Forecast | Difference |
|---|---|---|---|
| Quarter | +18.7% | +789.6% | +770.9 pp |
| 1 year | +28.1% | +2.8% | -25.3 pp |
| 3-year CAGR | — | +29.7% | — |
| 5-year CAGR | — | — | |
| 10-year CAGR | — | — |
Forecasts compare the consensus estimate with the latest reported period. Difference is forecast minus past, in percentage points.
EBITDA history
CAD · from the income statement
- Latest · FY2025
- 10.65M CAD
- Year-over-year change
- +28.1%
| Period | Period end | EBITDA | YoY change |
|---|---|---|---|
| FY2025 | 2025-12-31 | 10.65M | +28.1% |
| FY2024 | 2024-12-31 | 8.31M | +347.4% |
| FY2023 | 2023-12-31 | 1.86M | +357.7% |
| FY2022 | 2022-12-31 | (721K) | +94.9% |
| FY2021 | 2021-12-31 | (14.25M) | — |
EBITDA vs competitors
How KITS.TO compares with its peers on the latest reported figures
- KITS.TO's LTM Mar 2026 EBITDA of CA$10M is the lowest of the 10 companies compared; the peer median is CA$46.7M.
- Its year-over-year change of -2.5% is the 5th highest of 10, against a peer median of -8.1%.
- EBITDA amounts to 4.7% of revenue for KITS.TO, versus a peer median of 12.5%.
| Company | Period | LTM | YoY | 3-year CAGR | % of revenue |
|---|---|---|---|---|---|
| LTM Mar 2026 | CA$148.83M | -15.1% | -8.8% | 3.1% | |
| LTM Mar 2026 | CA$67.95M | -14.3% | +9.2% | 11.1% | |
| LTM Mar 2026 | CA$56.18M | +112.7% | +23.9% | 70.9% | |
| LTM Mar 2026 | CA$54.68M | -52.6% | -11.3% | 9.2% | |
| LTM Mar 2026 | CA$46.7M | -36.6% | -8.5% | 21.0% | |
| LTM Mar 2026 | CA$39.78M | +0.5% | +3.7% | 98.3% | |
| LTM Apr 2026 | CA$35.05M | +694.5% | -3.7% | 12.5% | |
| LTM Apr 2026 | CA$31.85M | +101.8% | -30.0% | 5.2% | |
| LTM Mar 2026 | CA$30.33M | -8.1% | +11.7% | 36.0% | |
| LTM Mar 2026 | CA$10M | -2.5% | — | 4.7% | |
| Peer median (excluding KITS.TO) | CA$46.7M | -8.1% | -3.7% | 12.5% | |
Competitors are the stored peer set for KITS.TO. Fiscal calendars differ, so each company's latest period is shown. Text is generated from reported figures; not investment advice.
Income Statement
Metric | FY2021 Dec 2021 | FY2022 Dec 2022 | FY2023 Dec 2023 | FY2024 Dec 2024 | FY2025 Dec 2025 |
|---|---|---|---|---|---|
| Revenue | 82.4M | 91.64M | 120.51M | 159.34M | 202.46M |
| Cost of Revenue | 61.51M | 62.39M | 79.72M | 105.69M | 131.18M |
| Gross Profit | 20.89M | 29.25M | 40.79M | 53.65M | 71.28M |
| Gross Margin | 25.4% | 31.9% | 33.8% | 33.7% | 35.2% |
| Research & Development | 817K | 681K | 817K | 0 | 0 |
| Selling, General & Admin | 35.56M | 33.65M | 24.91M | 32.09M | 47.06M |
| Operating Expenses | 37.94M | 33.6M | 43.17M | 48.22M | 63.02M |
| Depreciation & Amortization | 2.38M | 3.52M | 3.19M | 2.66M | 2.38M |
| EBITDA | (14.25M) | (721K) | 1.86M | 8.31M | 10.65M |
| EBITDA Margin | -17.3% | -0.8% | 1.5% | 5.2% | 5.3% |
| Operating Income | (17.05M) | (4.35M) | (2.38M) | 5.43M | 8.27M |
| Operating Margin | -20.7% | -4.7% | -2.0% | 3.4% | 4.1% |
| Interest Income | 67K | 107K | 585K | 580K | 210K |
| Interest Expense | 2.22M | 1.63M | 1.56M | 1.56M | 680K |
| Other Income / Expenses | (1.8M) | (1.52M) | (509K) | (975K) | (3.22M) |
| Income Before Tax | (18.84M) | (5.88M) | (2.89M) | 4.45M | 5.05M |
| Pre-Tax Margin | -22.9% | -6.4% | -2.4% | 2.8% | 2.5% |
| Income Tax Expense | (4.23M) | (1.32M) | (676K) | 1.34M | 1.94M |
| Net Income | (14.62M) | (4.55M) | (2.22M) | 3.12M | 3.11M |
| Net Margin | -17.7% | -5.0% | -1.8% | 2.0% | 1.5% |
| EPS (Basic) | (0.47) | (0.15) | (0.07) | 0.10 | 0.10 |
| EPS (Diluted) | (0.47) | (0.15) | (0.07) | 0.09 | 0.09 |
| Weighted Avg Shares | 31.16M | 31.27M | 31.39M | 31.52M | 32.05M |
| Weighted Avg Shares (Diluted) | 31.16M | 31.27M | 31.39M | 33.75M | 33.95M |
Kits Eyecare Ltd.
TSX:KITS.TO
Intrinsic Alpha fair value
Locked
Current Price
$19.13
Unlock the intrinsic value to see where the current price sits on the valuation runway.
Valuation runway
LockedGet the intrinsic value and margin of safety with a free account.
Continue the stock analysis
Jump to another research area for this company.